Dewanjee Saikat, Dua Tarun K, Bhattacharjee Niloy, Das Anup, Gangopadhyay Moumita, Khanra Ritu, Joardar Swarnalata, Riaz Muhammad, Feo Vincenzo De, Zia-Ul-Haq Muhammad
Advanced Pharmacognosy Research Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Raja S C Mullick Road, Kolkata 700032, India.
Department of Pharmaceutical Technology, ADAMAS University, Barasat, Kolkata 700126, India.
Molecules. 2017 May 25;22(6):871. doi: 10.3390/molecules22060871.
Multidrug resistance (MDR) is regarded as one of the bottlenecks of successful clinical treatment for numerous chemotherapeutic agents. Multiple key regulators are alleged to be responsible for MDR and making the treatment regimens ineffective. In this review, we discuss MDR in relation to P-glycoprotein (P-gp) and its down-regulation by natural bioactive molecules. P-gp, a unique ATP-dependent membrane transport protein, is one of those key regulators which are present in the lining of the colon, endothelial cells of the blood brain barrier (BBB), bile duct, adrenal gland, kidney tubules, small intestine, pancreatic ducts and in many other tissues like heart, lungs, spleen, skeletal muscles, etc. Due to its diverse tissue distribution, P-gp is a novel protective barrier to stop the intake of xenobiotics into the human body. Over-expression of P-gp leads to decreased intracellular accretion of many chemotherapeutic agents thus assisting in the development of MDR. Eventually, the effectiveness of these drugs is decreased. P-gp inhibitors act by altering intracellular ATP levels which are the source of energy and/or by affecting membrane contours to increase permeability. However, the use of synthetic inhibitors is known to cause serious toxicities. For this reason, the search for more potent and less toxic P-gp inhibitors of natural origin is underway. The present review aims to recapitulate the research findings on bioactive constituents of natural origin with P-gp inhibition characteristics. Natural bioactive constituents with P-gp modulating effects offer great potential for semi-synthetic modification to produce new scaffolds which could serve as valuable investigative tools to recognize the function of complex ABC transporters apart from evading the systemic toxicities shown by synthetic counterparts. Despite the many published scientific findings encompassing P-gp inhibitors, however, this article stand alones because it provides a vivid picture to the readers pertaining to Pgp inhibitors obtained from natural sources coupled with their mode of action and structures. It provides first-hand information to the scientists working in the field of drug discovery to further synthesise and discover new P-gp inhibitors with less toxicity and more efficacies.
多药耐药性(MDR)被认为是众多化疗药物临床治疗成功的瓶颈之一。据称,多种关键调节因子与多药耐药性有关,并导致治疗方案无效。在本综述中,我们讨论了与P-糖蛋白(P-gp)相关的多药耐药性及其被天然生物活性分子下调的情况。P-gp是一种独特的ATP依赖性膜转运蛋白,是存在于结肠内衬、血脑屏障(BBB)的内皮细胞、胆管、肾上腺、肾小管、小肠、胰管以及心脏、肺、脾脏、骨骼肌等许多其他组织中的关键调节因子之一。由于其多样的组织分布,P-gp是阻止外源性物质进入人体的新型保护屏障。P-gp的过度表达导致许多化疗药物的细胞内蓄积减少,从而促进了多药耐药性的发展。最终,这些药物的有效性降低。P-gp抑制剂通过改变作为能量来源的细胞内ATP水平和/或通过影响膜轮廓以增加通透性来发挥作用。然而,已知使用合成抑制剂会导致严重的毒性。因此,正在寻找更有效且毒性更小的天然来源的P-gp抑制剂。本综述旨在概括具有P-gp抑制特性的天然来源生物活性成分的研究结果。具有P-gp调节作用的天然生物活性成分具有巨大的半合成修饰潜力,可产生新的支架,这些支架除了能避免合成类似物所显示的全身毒性外,还可作为有价值的研究工具来识别复杂ABC转运蛋白的功能。尽管已经发表了许多关于P-gp抑制剂的科学发现,但本文独树一帜,因为它为读者提供了一幅关于从天然来源获得的Pgp抑制剂及其作用方式和结构的生动画面。它为从事药物发现领域的科学家提供了第一手信息,以进一步合成和发现毒性更小、疗效更高的新P-gp抑制剂。